Does disease activity add to functional disability in estimation of utility for rheumatoid arthritis patients on biologic treatment?

Autor: G. Ardine de Wit, Jacob M. van Laar, Johannes W. J. Bijlsma, Floris P J G Lafeber, Paulina Sijtsma, AK Marijnissen, Sandhya C. Nair, Paco M J Welsing
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
Multivariate analysis
Severity of Illness Index
Arthritis
Rheumatoid

Disability Evaluation
QALY
0302 clinical medicine
Surveys and Questionnaires
Activities of Daily Living
Pharmacology (medical)
mapping
skin and connective tissue diseases
Non-U.S. Gov't
030503 health policy & services
Research Support
Non-U.S. Gov't

Middle Aged
Prognosis
Explained variation
Rheumatoid arthritis
Female
0305 other medical science
Cohort study
musculoskeletal diseases
medicine.medical_specialty
Mean squared error
Observational Study
Motor Activity
Research Support
03 medical and health sciences
Rheumatology
Internal medicine
Severity of illness
EQ5D
medicine
Journal Article
Humans
DAS28
biologics
functional limitation
030203 arthritis & rheumatology
Biological Products
business.industry
prediction
HAQ
medicine.disease
utility
Physical therapy
Observational study
business
human activities
Follow-Up Studies
Zdroj: Rheumatology (Oxford, England), 55(1), 94. Oxford University Press
ISSN: 1462-0324
DOI: 10.1093/rheumatology/kev291
Popis: Objective. Treatment in general is mostly directly aimed at disease activity, and measures such as the DAS28 might therefore present important additional information. Our aim was to develop and validate a model that uses a combination of disease activity (DAS28) and HAQs to estimate EuroQoL 5-dimension scale (EQ5D) utilities. Methods. Longitudinal data from a cohort study in RA patients from the Utrecht Rheumatoid Arthritis Cohort study Group (Stichting Reumaonderzoek Utrecht) who started treatment with a biologic drug were used for mapping and validation. All 702 observations, including DAS28, HAQ and EQ5D assessed at the same time points, were used. The observations were randomly divided into a subset for development of the model (n = 428 observations) and a subset for validation (n = 274). A stepwise multivariable regression analysis was used to test the association of DAS28 (components) and HAQ (domains) with EQ5D. Model performance was assessed using the explained variance (R2) and root mean square errors. Observed and predicted utility scores were compared to check for under- or overestimation of the scores. Finally, the performance of the model was compared with published mapping models. Results. Lower DAS28 score and HAQ items dressing and grooming, arising, eating, walking and activities were associated with higher EQ5D scores. The final model had an explained variance of 0.35 and a lower root mean square error as compared with other models tested. The agreement between predicted and observed scores was fair. Conclusion. HAQ components estimate EQ5D better than total HAQ. Adding DAS28 to HAQ components does not result in better utility estimations.
Databáze: OpenAIRE